Fab portion of dupilumab with Crystal Kappa design
External Resource: Annotation
Chains | Family Name | Domain Identifier | Architecture | Possible Homology | Homology | Topology | Family | Provenance Source (Version) |
A | PF07654 | e6wg8A2 | A: beta sandwiches | X: Immunoglobulin-like beta-sandwich | H: Immunoglobulin-related | T: Immunoglobulin/Fibronectin type III/E set domains/PapD-like | F: PF07654 | ECOD (1.6) |
A | PF07686 | e6wg8A1 | A: beta sandwiches | X: Immunoglobulin-like beta-sandwich | H: Immunoglobulin-related | T: Immunoglobulin/Fibronectin type III/E set domains/PapD-like | F: PF07686 | ECOD (1.6) |
B | PF07654 | e6wg8B2 | A: beta sandwiches | X: Immunoglobulin-like beta-sandwich | H: Immunoglobulin-related | T: Immunoglobulin/Fibronectin type III/E set domains/PapD-like | F: PF07654 | ECOD (1.6) |
B | PF07686 | e6wg8B1 | A: beta sandwiches | X: Immunoglobulin-like beta-sandwich | H: Immunoglobulin-related | T: Immunoglobulin/Fibronectin type III/E set domains/PapD-like | F: PF07686 | ECOD (1.6) |
Chain | Protein Name | Description | Organism Name | Gene Allele Name(s) | Domain Name(s) | Receptor Type | Receptor Description | Provenance Source |
---|
| Fab Dupilumab | VH-CH1 | Homo sapiens (human) | IGHV3-23*04, IGHJ6*01, IGHG4*01, IGHG4*04 | V-DOMAIN VH, C-DOMAIN CH1 | IG | FAB-GAMMA-4_KAPPA | IMGT (202431-0) |
| Fab Dupilumab | L-KAPPA | Homo sapiens (human) | IGKV2-28*01, IGKV2D-28*01, IGKJ2*01, IGKC*01 | V-DOMAIN V-KAPPA, C-DOMAIN C-KAPPA | IG | FAB-GAMMA-4_KAPPA | IMGT (202431-0) |
Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
---|
| Heavy Chain | IGHV3 | - | - | SAbDab (2024-08-09) |
| Light Chain | IGKV2 | Kappa | - | SAbDab (2024-08-09) |
Chain | Name | Target | Provenance Source |
---|
| Dupilumab | IL4R | Therapeutic SAbDab (2024-08-09) |
| Dupilumab | IL4R | Therapeutic SAbDab (2024-08-09) |